These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
o
|
Preliminary
Proxy Statement
|
|
o
|
Confidential, for Use of the
Commission Only (as permitted by Rule
14a-6(e)(2))
|
|
þ
|
Definitive
Proxy Statement
|
|
o
|
Definitive
Additional Materials
|
|
o
|
Soliciting
Material under §240.14a-12
|
|
o
|
No
fee required.
|
|
o
|
Fee
computed on table below per Exchange Act Rules 14a-6(i)(1)
and 0-11.
|
|
(1)
|
Title
of each class of securities to which transaction
applies:
|
|
(2)
|
Aggregate
number of securities to which transaction
applies:
|
|
|
(3)
|
Per
unit price or other underlying value of transaction computed pursuant to
Exchange Act Rule 0-11 (set forth the amount on which the filing fee is
calculated and state how it was
determined):
|
|
(4)
|
Proposed
maximum aggregate value of
transaction:
|
|
(5)
|
Total
fee paid:
|
|
o
|
Fee
paid previously with preliminary
materials.
|
|
o
|
Check
box if any part of the fee is offset as provided by Exchange Act
Rule 0-11(a)(2) and identify the filing for which the offsetting fee
was paid previously. Identify the previous filing by registration
statement number, or the Form or Schedule and the date of its
filing.
|
|
(1)
|
Amount
Previously Paid:
|
|
(2)
|
Form,
Schedule or Registration Statement
No.:
|
|
(3)
|
Filing
Party:
|
|
(4)
|
Date
Filed:
|

|
|
1.
|
Elect
the five nominees to our Board of Directors named herein to serve for the
ensuing year;
|
|
|
2.
|
Ratify
the appointment of Habif, Arogeti & Wynne, LLP as our independent
registered public accounting firm for our fiscal year ending on
December 31, 2010; and
|
|
|
3.
|
Transact
any other business that may properly come before the
meeting.
|
|
Sincerely,
|
|
|
William
R. Doyle
|
|
|
Chairman,
CEO and President
|
|
INFORMATION CONCERNING SOLICITATION AND
VOTING
|
1
|
|
|
QUESTIONS AND ANSWERS
|
1
|
|
|
PROPOSAL 1 ELECTION OF
DIRECTORS
|
3
|
|
|
PROPOSAL 2 RATIFICATION OF APPOINTMENT OF
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
|
8
|
|
|
PRINCIPAL ACCOUNTING FEES AND
SERVICES
|
9
|
|
|
AUDIT COMMITTEE PRE-APPROVAL OF SERVICES PERFORMED
BY OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS
|
9
|
|
|
REPORT OF THE AUDIT
COMMITTEE*
|
10
|
|
|
CORPORATE GOVERNANCE
|
11
|
|
|
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS
AND MANAGEMENT
|
11
|
|
|
SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING
COMPLIANCE
|
12
|
|
|
EQUITY COMPENSATION PLAN
INFORMATION
|
13
|
|
|
COMPENSATION DISCUSSION AND
ANALYSIS
|
14
|
|
|
COMPENSATION COMMITTEE
REPORT*
|
15
|
|
|
EXECUTIVE COMPENSATION
|
16
|
|
|
Summary Compensation Table
|
16
|
|
|
Employment Agreements
|
17
|
|
|
Grants of Plan-Based Awards for Fiscal Year
2009
|
18
|
|
|
Outstanding Equity Awards at Fiscal
Year-End
|
18
|
|
|
Risk Analysis of Performance-Based Compensation
Programs
|
19
|
|
|
Retirement and Deferred Compensation Plan
Benefits
|
20
|
|
|
Perquisites and Additional Benefits and
Programs
|
20
|
|
|
Potential Payments upon Termination Without
Cause
|
20
|
|
|
DIRECTOR COMPENSATION
|
21
|
|
|
COMPENSATION COMMITTEE INTERLOCKS AND INSIDER
PARTICIPATION
|
21
|
|
|
TRANSACTIONS WITH RELATED
PERSONS
|
21
|
|
|
ANNUAL REPORT
|
22
|
|
|
SHAREHOLDER PROPOSALS TO BE PRESENTED AT NEXT
ANNUAL MEETING
|
|
23
|
|
Q:
|
Who
may vote at the meeting?
|
|
A:
|
Our
Board set April 2, 2010, as the record date for the meeting. If you owned
our common stock at the close of business on April 2, 2010, you may attend
and vote at the meeting. Each shareholder is entitled to one vote for each
share of common stock held on all matters to be voted on. As of April 2,
2010, there were 13,916,524 shares of our common stock outstanding and
entitled to vote at the meeting.
|
|
Q:
|
What
is the quorum requirement for the
meeting?
|
|
A:
|
A
majority of our outstanding shares as of the record date must be present
at the meeting in order to hold the meeting and conduct business. This is
called a quorum.
|
|
|
Your
shares will be counted as present at the meeting if
you:
|
|
|
§
|
are
present and entitled to vote in person at the meeting;
or
|
|
|
§
|
have
properly submitted a proxy card or voting instruction
card.
|
|
|
Both
abstentions and broker non-votes (as described below) are counted for the
purpose of determining the presence of a
quorum.
|
|
|
Each
proposal identifies the votes needed to approve or ratify the proposed
action.
|
|
Q:
|
What
proposals will be voted on at the
meeting?
|
|
A:
|
There
are two proposals scheduled to be voted on at the
meeting:
|
|
|
§
|
Election
of the five members of our Board named
herein;
|
|
|
§
|
Ratification
of Habif, Arogeti & Wynne, LLP as our independent registered public
accounting firm.
|
|
|
We
will also consider any other business that properly comes before the
meeting. As of the record date, we are not aware of any other matters to
be submitted for consideration at the meeting. If any other matters are
properly brought before the meeting, the persons named in the enclosed
proxy card or voter instruction card will vote the shares they represent
using their best judgment.
|
|
Q:
|
How
may I vote my shares in person at the
meeting?
|
|
A:
|
If
your shares are registered directly in your name with our transfer agent,
Island Stock Transfer, you are considered, with respect to those shares,
the shareholder of record. As the shareholder of record, you have the
right to vote in person at the meeting. If your shares are held in a
brokerage account or by another nominee or trustee, you are considered the
beneficial owner of shares held in street name. As the beneficial owner,
you are also invited to attend the meeting. Since a beneficial owner is
not the shareholder of record, you may not vote these shares in person at
the meeting unless you obtain a “legal proxy” from your broker, nominee,
or trustee that holds your shares, giving you the right to vote the shares
at the meeting. The meeting will be held at the Atlanta Marriott Gwinnett
Place Hotel, 1775 Pleasant Hill Road, Duluth, GA. If you need directions
to the meeting, please visit www.marriott.com/hotels/maps/directions/atlgp-atlanta-marriott-gwinnett-place.com.
|
|
Q:
|
How
can I vote my shares without attending the
meeting?
|
|
A:
|
Whether
you hold shares directly as a registered shareholder of record or
beneficially in street name, you may vote without attending the meeting.
You may vote by granting a proxy or, for shares held beneficially in
street name, by submitting voting instructions to your stockbroker,
trustee or nominee. You will be able to do this by submitting your proxy
by mail by signing your proxy card if your shares are registered or, for
shares held beneficially in street name, by following the voting
instructions included by your stockbroker, trustee or nominee, and mailing
it in the enclosed envelope. If you provide specific voting instructions,
your shares will be voted as you have
instructed.
|
|
Q:
|
What
happens if I do not give specific voting
instructions?
|
|
A:
|
Registered
Shareholder of Record. If you are a registered shareholder of
record and you sign and return a proxy card without giving specific voting
instructions then the proxy holders will vote your shares in the manner
recommended by the Board on all matters presented in this proxy statement
and as the proxy holders may determine in their discretion with respect to
any other matters properly presented for a vote at the
meeting.
|
|
|
Beneficial
Owners of Shares Held in Street Name. If you are a beneficial
owner of shares held in street name and do not provide the organization
that holds your shares with specific voting instructions, the organization
that holds your shares may generally vote at its discretion on routine
matters but cannot vote on non-routine matters. If the organization that
holds your shares does not receive instructions from you on how to vote
your shares on a non-routine matter, the organization will inform the
inspector of election that it does not have the authority to vote on this
matter with respect to your shares. This is generally referred to as a
“broker non-vote.” In tabulating the voting results for any particular
proposal, shares that constitute broker non-votes are not considered
entitled to vote on that proposal. Thus, broker non-votes will not affect
the outcome of any matter being voted on at the meeting, assuming that a
quorum is obtained.
|
|
Q.
|
Which
ballot measures are considered “routine” or
“non-routine?”
|
|
A.
|
The
ratification of the appointment of Habif, Arogeti & Wynne, LLP as the
Company’s independent registered public accounting firm for 2010 (Proposal
No. 2) is considered routine under applicable rules. A broker or
other nominee may generally vote on routine matters, and therefore no
broker non-votes are expected to exist in connection with Proposal
No. 2. The election of directors (Proposal No. 1) is considered
non-routine under applicable rules. A broker or other nominee cannot vote
without instructions on non-routine matters, and therefore there may be
broker non-votes on Proposal
No. 1.
|
|
Q:
|
How
can I revoke my proxy and change my vote after I return my proxy
card?
|
|
A:
|
You
may revoke your proxy and change your vote at any time before the final
vote at the meeting. If you are a shareholder of record, you may do this
by signing and submitting a new proxy card with a later date or by
attending the meeting and voting in person. Attending the meeting alone
will not revoke your proxy unless you specifically request your proxy to
be revoked. If you hold shares through a bank or brokerage firm, you must
contact that bank or firm directly to revoke any prior voting
instructions.
|
|
Q:
|
Where
can I find the voting results of the
meeting?
|
|
A:
|
The
preliminary voting results will be announced at the meeting. The final
voting results will be reported in a current report on Form 8-K,
which will be filed with the SEC within four business days after the
meeting. If our final voting results are not available within four
business days after the meeting, we will file a current report on
Form 8-K reporting the preliminary voting results and subsequently
file the final voting results in an amendment to the current report on
Form 8-K within four business days after the final voting results are
known to us.
|
|
Name
|
Principal Occupation During Last Five Years
|
Age
|
Director
Since
|
|||
|
William R. Doyle
|
Mr.
Doyle, the Chairman of the Board, President and Chief Executive Officer,
joined Vystar in 2004 as Vice President Sales &
Marketing. He became President and Chief Operating Officer in
December 2005. He became Chairman of the Board, President and
Chief Executive Officer of Vystar in March 2008. Prior to that,
Mr. Doyle served as Vice President of Marketing, Women’s Health, for
Matria Healthcare, Inc., a disease management company,
from 1999 to 2004. Mr. Doyle spearheaded the initial branding
efforts at Matria as well as held responsibility for sales development,
training, public relations, and marketing. He has worked in many aspects
of healthcare industry for over twenty years encompassing manufacturing,
sales, marketing and advertising. In addition to Matria, he has experience
with such companies as Isolyser Company, Inc., McGaw, Inc., Lederle
Laboratories (now Wyeth), and in an advertising capacity for Novartis
Ophthalmics. Mr. Doyle is a member of the Board of Directors of the
Georgia Chapter of the March of Dimes. He holds a Bachelor of Science in
Biochemistry from Penn State University and Master of Business
Administration from Pepperdine University.
|
52
|
2005
|
|||
|
J.
Douglas Craft
|
Since
1983, Mr. Craft has been the founder and chief executive officer of
Atlanta-based Medicraft Inc., one of the largest independent distributors
for Medtronic Spinal Products worldwide. Mr. Craft has more than 25 years
experience in the medical device arena and holds a biomedical engineering
degree from Mississippi State University.
|
48
|
2006
|
|||
|
Joseph
C. Allegra, M.D.
|
Dr.
Allegra was previously a member of Vystar’s Board from April 2008 to June
2009, and recently rejoined Vystar’s Board in September
2009. Dr. Allegra is the founder/owner of various limited
liability companies in the Atlanta area including Diamond II Investments,
Oncology Molecular Imaging, and Kids'Time Pediatrics. He is
also the owner of Cyberlogistics, Inc and is a partner with the Seraph
Group. Dr. Allegra has held various professorships and
chairmanships as a practicing oncologist. He has an
undergraduate degree in Chemistry from Temple University and obtained his
MD from the Milton S. Hershey Medical Center of the Pennsylvania State
University.
|
61
|
2009
|
|||
|
Mitsy
Y. Mangum
|
From
July 2009 to present, Ms Mangum has been Vice President, Investments, WMS,
RPC at MidSouth Capital, Inc., an independent investment banking firm in
Atlanta, GA. From July 2004 to July 2009, Ms. Mangum was
a Vice President-Investments, Financial Advisor WMS, RPC with Raymond
James & Associates in the Atlanta area. Ms. Mangum is an accomplished
investment professional with over 22 years of financial service and
industry experience both from the retail side as well as the institutional
side. Ms. Mangum maintains an in-depth knowledge of the financial markets,
professional money management and managing portfolios. She has a Bachelor
of Science in Business Administration/ Management from College of
Charleston.
|
46
|
2008
|
|
W.
Dean Waters
|
|
Mr.
Waters founded and is
Managing Director of FiveFold Capital, a company focused on the capital
needs of community banks. Mr. Waters has more than nineteen years of
diversified business experience, fifteen of which has been focused on
raising capital. Over his career, Mr. Waters has raised both equity
and debt financings totaling more than $5 billion. Prior to FiveFold
Capital, he was Senior Vice President in Commerce Street Capital’s Bank
Development Group managing both initial and secondary community bank
capital offerings. Mr. Waters founded and was Managing Partner of
Poseidon Capital Investments, LLC and was Director of Equity and Debt
Syndications at Global Capital Finance. He was Senior Vice
President, Director and one of the founding members of the Capital Markets
Group within GMAC Commercial Finance’s Equipment Finance Division.
Mr. Waters began his finance career at NationsBank, predecessor to the
current Bank of America and in less than five years became the Managing
Director of Equity Distributions of Bank of America Leasing & Capital
Group. Mr. Waters received a B.S. in Economics from East
Carolina University in Greenville, N.C., and earned an M.B.A., with
honors, from Wake Forest University’s Babcock Graduate School of
Management in Winston-Salem, N.C. He also represented Wake Forest in
the European Business Studies program at St. Peters College of Oxford
University and served eight years as a board member on the Babcock
Graduate School of Management’s Alumni Council. He holds multiple
securities licenses.
|
|
44
|
|
2008
|
|
|
·
|
appointing,
approving the compensation of, and assessing the independence of our
independent registered public accounting
firm;
|
|
|
·
|
overseeing
the work of our independent registered public accounting firm, including
through the receipt and consideration of reports from such
firm;
|
|
|
·
|
reviewing
and discussing with management and the independent registered public
accounting firm our annual and quarterly financial statements and related
disclosures;
|
|
|
·
|
monitoring
our internal control over financial reporting, disclosure controls and
procedures and code of business conduct and
ethics;
|
|
|
·
|
discussing
our risk management policies;
|
|
|
·
|
establishing
policies regarding hiring employees from the independent registered public
accounting firm and procedures for the receipt and resolution of
accounting related complaints and
concerns;
|
|
|
·
|
meeting
independently with our independent registered public accounting firm and
management;
|
|
|
·
|
reviewing
and approving or ratifying any related person
transactions; and
|
|
|
·
|
preparing
the audit committee report required by SEC
rules.
|
|
|
·
|
annually
reviewing and approving corporate goals and objectives relevant to chief
executive officer compensation;
|
|
|
·
|
determining
our chief executive officer’s
compensation;
|
|
|
·
|
reviewing
and approving, or making recommendations to our Board with respect to, the
compensation of our other executive
officers;
|
|
|
·
|
overseeing
an evaluation of our senior
executives;
|
|
|
·
|
overseeing
and administering our cash and equity incentive
plans;
|
|
|
·
|
reviewing
and making recommendations to our Board with respect to director
compensation;
|
|
|
·
|
reviewing
and discussing annually with management our “Compensation Discussion and
Analysis” disclosure required by SEC
rules; and
|
|
|
·
|
preparing
the compensation committee report required by SEC
rules.
|
|
Name
|
Board(1)
|
Audit
|
Compensation(2)
|
|||
|
Mr. Doyle
|
Chair
|
|||||
|
Mr. Craft
|
X
|
X
|
X
|
|||
|
Dr.
Allegra
|
X
|
Chair
|
||||
|
Ms.
Mangum
|
X
|
X
|
||||
|
Mr.
Waters
|
X
|
Chair
|
X
|
|||
|
Number
of meetings held in fiscal year 2009
|
|
4
|
|
0
|
|
0
|
|
(1)
|
From
January 1, 2009, to June 2009, and from September 2009 for the balance of
2009, our Board was composed of Mr. Doyle (Chair), Mr. Craft,
Dr. Allegra, Ms. Mangum and Mr. Waters. From June 2009 to
September 2009, our Board was composed of Mr. Doyle (Chair), Mr.
Craft, Ms. Mangum and Mr. Waters.
|
|
(2)
|
From
January 1, 2009, to June 2009, and from September 2009 for the balance of
2009, our Compensation Committee was composed of Dr. Allegra (Chair), Mr.
Craft and Mr. Waters. From June 2009 to September 2009, our
Compensation Committee was composed of Mr. Waters (Chair) and Ms.
Mangum.
|
|
Fee
Category
|
2009
|
2008
|
||||||
|
Audit
Fees
|
$ | 113,394 | $ | 149,148 | (1) | |||
|
Audit-Related
Fees
|
$ | - | $ | - | ||||
|
Tax
Fees
|
$ | 3,000 | $ | 6,000 | (2) | |||
|
All
Other Fees
|
$ | - | $ | - | ||||
|
Total
|
$ | 116,394 | $ | 155,148 | ||||
|
*
|
The material in this report is
not “soliciting material,” is not deemed “filed” with the SEC and is not
to be incorporated by reference into any filing of Vystar under the
Securities Act of 1933 or the Securities Exchange Act of 1934, whether
made before or after the date hereof and irrespective of any general
incorporation language in any such
filing
|
|
5%
Stockholders:
|
||||||||
|
Travis
W. Honeycutt
Gainesville,
GA
|
2,496,900 | 17.94 | % | |||||
|
Margaret
S. Honeycutt
Gainesville,
GA
|
2,497,000 | 17.94 | % | |||||
|
Universal
Capital Management, Inc.(1)
2601
Annand Dr., #16
Wilmington,
DE 19808
|
1,319,023 | 9.15 | % | |||||
|
Glen
Smotherman
Norcross,
GA
|
971,800 | 6.98 | % | |||||
|
Directors
and Executive Officers
|
||||||||
|
William
Doyle* (2)
|
2,690,000 | 16.22 | % | |||||
|
Matthew
Clark* (3)
|
558,667 | 3.91 | % | |||||
|
Sandra
Parker* (4)
|
205,282 | 1.46 | % | |||||
|
Linda
S. Hammock* (5)
|
10,000 | 0.07 | % | |||||
|
J.
Douglas Craft (6)
|
380,000 | 2.67 | % | |||||
|
Atlanta,
GA
|
||||||||
|
Joseph C.
Allegra, M.D. (7)
|
515,000 | 3.65 | % | |||||
|
Atlanta,
GA
|
||||||||
|
W.
Dean Waters (8)
|
244,334 | 1.74 | % | |||||
|
Atlanta,
GA
|
||||||||
|
Mitsy
Y. Mangum (8)
|
155,000 | 1.10 | % | |||||
|
Atlanta,
GA
|
||||||||
|
All
directors and executive officers (as a group)
|
4,758,283 | 26.60 | % | |||||
|
(1)
|
Includes
warrants to acquire 500,000 shares of common stock at $2.00 per
share.
|
|
(2)
|
Includes
options and warrants to acquire 2,670,000 shares of common stock at a
weighted average price of $1.03 per
share.
|
|
(3)
|
Includes
options to acquire 371,667 shares of common stock at a weighted average
price of $1.04 per share.
|
|
(4)
|
Includes
options and warrants to acquire 185,282 shares of common stock at a
weighted average price of $1.15 per
share.
|
|
(5)
|
Consists
of options to acquire shares of common stock at $1.63 per
share.
|
|
(6)
|
Includes options
and warrants to acquire 305,000 shares of common stock at a weighted
average price of $1.40 per share.
|
|
(7)
|
Includes options
and warrants to acquire 190,000 shares of common stock at a weighted
average price of $1.82 per share.
|
|
(8)
|
Includes
options and warrants to acquire 120,000 shares of common stock at an
exercise price of $1.63 per share.
|
|
Plan
Category
|
Number of securities
to be issued upon
exercise of
outstanding options
by Executive Officers
|
Weighted
average
exercise price
of outstanding
options
|
Number of
securities
remaining available
for future issuance
under equity
compensation plans
(excluding
securities reflected
in first column)
|
|||||||||
|
2004
Long-Term Incentive Compensation Plan, as amended, approved by
shareholders
|
4,925,000 | $ | 1.2308 | 4,825,000 | ||||||||
|
Total
|
4,925,000 | $ | 1.2308 | 4,825,000 | ||||||||
|
|
·
|
the
number of shares of common stock covered by options and the dates upon
which those options become
exercisable;
|
|
|
·
|
the
exercise prices of options;
|
|
|
·
|
the
duration of options;
|
|
|
·
|
the
methods of payment of the exercise
price; and
|
|
|
·
|
the
number of shares of common stock subject to any restricted stock or other
stock-based awards and the terms and conditions of those awards, including
the conditions for repurchase, issue price and repurchase
price.
|
|
|
·
|
attract,
retain and motivate talented
executives;
|
|
|
·
|
promote
the achievement of key financial and strategic performance measures by
linking short- and long-term cash and equity incentives to the achievement
of measurable corporate and, in some cases, individual performance
goals; and
|
|
|
·
|
align
the incentives of our executives with the creation of value for our
shareholders.
|
|
|
·
|
base
salary;
|
|
|
·
|
cash
incentive bonuses;
|
|
|
·
|
equity
incentive awards;
|
|
|
·
|
termination
benefits upon termination without
cause; and
|
|
|
·
|
insurance
and other employee benefits and
compensation.
|
|
Option
|
All Other
|
|||||||||||||||
|
Awards
|
Compensation
|
|||||||||||||||
|
Name and Principal Position
|
Salary
|
(1)
|
(2)
|
Total
|
||||||||||||
|
William
R. Doyle
|
||||||||||||||||
|
Chairman,
Chief Executive Officer and President
|
||||||||||||||||
|
2009
|
$ | 185,000 | $ | - | $ | 3,128 | $ | 188,128 | ||||||||
|
2008
|
$ | 169,519 | $ | 1,172,747 | $ | 2,283 | $ | 1,344,549 | ||||||||
|
2007
|
$ | 168,750 | $ | - | $ | 2,422 | $ | 171,172 | ||||||||
|
Travis
Honeycutt (3)
|
||||||||||||||||
|
Former
Chairman and Chief Executive Officer
|
||||||||||||||||
|
2009
|
$ | - | $ | - | $ | - | $ | - | ||||||||
|
2008
|
$ | 20,914 | $ | - | $ | 2,904 | $ | 23,818 | ||||||||
|
2007
|
$ | 196,875 | $ | - | $ | 12,574 | $ | 209,449 | ||||||||
|
Sandra
Parker (4)
|
||||||||||||||||
|
Executive Vice President of Sales and
Business Development
|
||||||||||||||||
|
2009
|
$ | 154,992 | $ | - | $ | 7,490 | $ | 162,482 | ||||||||
|
2008
|
$ | 126,750 | $ | 147,134 | $ | 4,370 | $ | 278,254 | ||||||||
|
2007
|
$ | - | $ | - | $ | - | $ | - | ||||||||
|
Matthew
P. Clark
|
||||||||||||||||
|
Vice
President of Technical Sales
|
||||||||||||||||
|
2009
|
$ | 84,999 | $ | 46,074 | $ | 18,392 | $ | 149,465 | ||||||||
|
2008
|
$ | 70,659 | $ | 167,535 | $ | 16,308 | $ | 254,501 | ||||||||
|
2007
|
$ | 75,833 | $ | 30,388 | $ | 16,327 | $ | 122,549 | ||||||||
|
Linda
S. Hammock (5)
|
||||||||||||||||
|
Acting
Chief Financial Officer
|
||||||||||||||||
|
2009
|
$ | - | $ | 55,142 | $ | - | $ | 55,142 | ||||||||
|
2008
|
$ | - | $ | - | $ | - | $ | - | ||||||||
|
2007
|
$ | - | $ | - | $ | - | $ | - | ||||||||
|
(1)
|
These
amounts do not reflect the actual economic value realized by the executive
officers. In accordance with SEC rules, this column represents the dollar
amount recognized as compensation expense by Vystar for financial
statement reporting purposes for fiscal years 2009, 2008 and 2007 for
stock options granted to each of the executive officers in fiscal years
2009, 2008 and 2007, respectively, as well as prior fiscal years, in
accordance with applicable accounting guidance related to stock-based
compensation. Pursuant to SEC rules, the amounts shown disregard the
impact of estimated forfeitures related to service-based vesting
conditions. No stock options were forfeited by any of the executive
officers in fiscal years 2009, 2008 or 2007. For additional information on
the valuation assumptions underlying the value of these awards, see the
Notes to Financial Statements at Note 9, “Stock-Based Compensation”
in our 2009 Annual Report on Form 10-K. The individual awards
reflected in this summary compensation table are further summarized below
under “Outstanding Equity Awards at Fiscal Year
End.”
|
|
(2)
|
Amounts
consist of medical, dental, vision, life insurance and disability
insurance premiums paid by us on behalf of the named executive
officer.
|
|
(3)
|
Mr.
Honeycutt resigned as Chairman and Chief Executive Officer of Vystar in
March, 2008.
|
|
(4)
|
Ms.
Parker was not an employee in 2007.
|
|
(5)
|
Ms.
Hammock is an employee of Accounting Professionals Network, Inc. (“APN”),
a provider of professional financial management services to companies. The
Company is billed by APN on a periodic basis for Ms. Hammock’s services.
APN was paid $65,157, $69,888 and $6,070 in 2009, 2008 and 2007,
respectively, for Ms. Hammock’s
services.
|
|
Executive Officer
|
Grant Date
|
All Other Option
Awards: Number
of Securities
Underlying
Options (1) (#)
|
Exercise or Base
Price of Option
Awards
($/Share)
|
Grant Date Fair
Value of Option
Awards(2)
|
||||||||||
|
Matthew
P. Clark
|
July
6, 2009,
and
July
22, 2009
|
75,000 | $ | 1.63 | $ | 46,074 | ||||||||
|
Linda
Hammock
|
August
7, 2009
and
September
1, 2009
|
50,000 | $ | 1.63 | $ | 55,142 | ||||||||
|
(1)
|
This
column represents awards of options under our 2004
Plan.
|
|
(2)
|
These
amounts do not reflect the actual economic value realized by the executive
officer. In accordance with SEC rules, this column represents the grant
date fair value of each equity award. For additional information on the
valuation assumptions underlying the value of these awards, see
Part II, Item 8 “Financial Statements and Supplementary Data” of
our 2009 Annual Report on Form 10-K and in the Notes to Consolidated
Financial Statements at Note 9, “Stock-Based
Compensation.”
|
|
Name
|
Number of Securities
Underlying
Unexercised Options
Exercisable(#)
|
Number of Securities
Underlying
Unexercised Options
Unexercisable (#)
|
Equity Incentive
Plan Awards:
Number of Securities
Underlying Unexercised
Unearned Options (#)
|
Options
Exercise
Price ($)
|
Option
Expiration
Date
|
||||||||||||
|
William R. Doyle
|
300,000 | 1.00 |
12/2/2014
|
||||||||||||||
| 100,000 | 1.50 |
4/28/2015
|
|||||||||||||||
| 500,000 | 1.00 |
10/1/2016
|
|||||||||||||||
| 1,750,000 | 1.00 |
2/11/2018
|
|||||||||||||||
|
Matthew
P. Clark
|
100,000 | 1.00 |
1/1/2017
|
||||||||||||||
| 250,000 | 1.00 |
2/11/2018
|
|||||||||||||||
| 16,667 | 33,333 | (1) | 33,333 | 1.63 |
7/6/2019
|
||||||||||||
| 5,000 | 20,000 | (2) | 20,000 | 1.63 |
7/22/2019
|
||||||||||||
|
Sandra
Parker
|
100,000 | 100,00 | (3) | 100,000 | 1.00 |
4/1/2018
|
|||||||||||
|
Linda
Hammock
|
5,000 | 20,000 | (4) | 20,000 | 1.63 |
8/7/2019
|
|||||||||||
| 5,000 | 20,000 | (5) | 20,000 | 1.63 |
9/1/2019
|
||||||||||||
|
(1)
|
The
remaining unvested portion of the option grants to Matthew P. Clark vest
16,667 on July 6, 2010 and 16,666 on July 6,
2011.
|
|
(2)
|
The
remaining unvested portion of the option grants to Matthew P. Clark vest
5,000 on each of July 22, 2010, 2011, 2012 and
2013.
|
|
(3)
|
The
remaining unvested portion of the option grants to Sandra Parker vest
50,000 each on April 1, 2010 and
2011.
|
|
(4)
|
The
remaining unvested portion of the option grants to Linda Hammock vest
5,000 each on August 7, 2010, 2011, 2012 and
2013.
|
|
(5)
|
The
remaining unvested portion of the option grants to Linda Hammock vest
5,000 each on September 1, 2010, 2011, 2012 and
2013.
|
|
|
§
|
health,
dental and vision
insurance;
|
|
|
§
|
life
insurance;
|
|
|
§
|
medical
and dependent care flexible spending account;
and
|
|
|
§
|
short-term
and long-term disability, accidental death and
dismemberment.
|
|
Executive Officer
|
Monthly
Severance
Programs (1)
|
Additional
Monthly Severance
Payments (2)
|
Continuing
Benefits (3)
|
TOTALS
|
||||||||||||
|
William
R. Doyle
|
$ | 92,500 | $ | 138,750 | $ | 962 | $ | 232,212 | ||||||||
|
Sandra
Parker
|
$ | 31,250 | — | $ | 1,338 | $ | 32,588 | |||||||||
|
Matthew
Clark
|
$ | 21,250 | — | $ | 3,920 | $ | 25,170 | |||||||||
|
(1)
|
The
amounts represent the aggregate of monthly payments for six (6) months for
Mr. Doyle and three (3) months for Ms. Parker and Mr.
Clark.
|
|
(2)
|
In
the event that Mr. Doyle complies with certain restrictive covenants in
his employment agreement, after termination without cause, he is
additionally entitled to this amount (75% of his base salary) payable in
monthly installments over a one (1) year period following the initial six
(6) month period of monthly severance
payments.
|
|
(3)
|
Consists
of health insurance premiums.
|
|
Name
|
Fees Earned or
Paid in Cash
($)
|
Stock Awards ($)
|
Option Awards
($) (1)
|
Total ($)(2)
|
||||||||||||
|
J.
Douglas Craft
|
0 | 0 | 244,079 | 244,079 | ||||||||||||
|
Joseph
Allegra, M.D.
|
0 | 0 | 256,285 | 256,285 | ||||||||||||
|
W.
Dean Waters
|
0 | 0 | 244,079 | 244,079 | ||||||||||||
|
Mitsy
Y. Mangum
|
0 | 0 | 244,079 | 244,079 | ||||||||||||
|
(1)
|
In
2009, all non-employee directors were granted 400,000 options at $1.63 per
share which vest 20,000 options at the end of each fiscal quarter for five
(5) years beginning June 30, 2009, for Messrs. Craft and Waters, and Ms.
Mangum, and beginning September 30, 2009 for Dr. Allegra. Such
vesting is based on each director’s continued service as a director at
each quarterly vesting date.
|
|
(2)
|
These
amounts do not reflect the actual economic value realized by the
directors. In accordance with SEC rules, this column represents the dollar
amount recognized as compensation expense by Vystar for financial
statement reporting purposes for fiscal year 2009 for stock options
granted to each of the non-employee directors in fiscal year 2009, in
accordance with applicable accounting guidance related to stock-based
compensation. Pursuant to SEC rules, the amounts shown disregard the
impact of estimated forfeitures related to service-based vesting
conditions. For additional information on the valuation assumptions
underlying the value of these awards, see the Notes to Financial
Statements at Note 9, “Stock-Based Compensation” in our 2009 Annual
Report on Form 10-K.
|
![]() |
.VOTE BY
MAIL
Mark,
sign and date your proxy card and return it in the postage-paid envelope
we have provided or return it to Vystar Corporation, c/o Island Stock
Transfer, 100 Second Avenue South, Suite 7055, St. Petersburg, FL
33701.
|
|
VYSTAR
CORPORATION
|
||||||||||||||
|
Vote on
Directors
|
||||||||||||||
|
|
||||||||||||||
|
The Board of
Directors recommends a
vote FOR all nominees. |
Vote on
Proposals
|
|||||||||||||
|
|
||||||||||||||
| The Board of Directors recommends a | ||||||||||||||
|
1.
|
Election
of the five (5) Directors proposed in the accompanying Proxy Statement to
serve for a one-year term.
|
For
|
Against
|
Abstain
|
vote
FOR
Proposal 2.
|
For
|
Against
|
Abstain
|
||||||
|
|
||||||||||||||
|
|
1a.
1b.
1c.
1d.
1e.
|
William
R. Doyle
J.
Douglas Craft
Joseph
Allegra MD
Mitsy
Y. Mangum
W.
Dean Waters
|
¨
¨
¨
¨
¨
|
¨
¨
¨
¨
¨
|
¨
¨
¨
¨
¨
|
2.
|
Ratification
of the appointment of Habif, Arogeti & Wynne, LLP as the
Company’s independent registered public accounting firm for the fiscal
year ending on December 31, 2010.
|
¨
o
|
¨
o
|
¨
o
|
||||
|
<
/font>
|
|
|
|
|||||||||||
|
Sign
exactly as your name(s) appear(s) on the stock certificate. If shares of
stock stand of record in the names of two or more persons, or in the name
of husband and wife, whether as joint tenants or otherwise, both or all of
such persons should sign the proxy card. If shares of stock are held of
record by a corporation, the proxy card should be executed by the
President or Vice President and the Secretary or Assistant Secretary.
Executors or administrators or other fiduciaries who execute the proxy
card for a deceased shareholder should give their full title. Please date
the proxy card.
|
||||||||||||||
|
|
||||||||||||||
|
Signature
[PLEASE SIGN WITHIN BOX]
|
Date
|
Signature
(Joint Owners)
|
Date
|
|||||||||||
|
VYSTAR
CORPORATION
PROXY
FOR ANNUAL MEETING OF SHAREHOLDERS
THIS
PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS OF THE
COMPANY
The
undersigned hereby appoints William R. Doyle and Dawn Ely, and each of
them, with full power of substitution, to represent the undersigned and to
vote all of the shares of stock in Vystar Corporation (the “Company”)
which the undersigned is entitled to vote at the Annual Meeting of
Shareholders of the Company, to be held at the Atlanta Marriott Gwinnett
Place Hotel, 1775 Pleasant Hill Road, Duluth, at 10:00 a.m. local time on
May 10, 2010, and at any adjournment or postponement thereof: (1) as
hereinafter specified upon the proposals listed on the reverse side and as
more particularly described in the Company’s Proxy Statement, receipt of
which is hereby acknowledged, and (2) in their discretion upon such other
matters as may properly come before the meeting.
The
shares represented hereby shall be voted as specified. If no specification is made,
such shares shall be voted FOR the election of the nominees listed on the
reverse side for the Board of Directors and for the proposal.
Whether or not you are able to attend the meeting, you are urged to sign
and mail the proxy card in the return envelope so that the stock may be
represented at the meeting.
IF
YOU ELECT TO VOTE BY MAIL, PLEASE MARK, SIGN, DATE AND RETURN THIS PROXY
CARD
PROMPTLY
USING
THE ENCLOSED ENVELOPE
(CONTINUED
AND TO BE SIGNED ON REVERSE SIDE)
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|